Georgiamune

Private

#Oncology #Autoimmune Diseases #Immuno-Oncology

Clinical-stage biotechnology company developing first-in-class oral small molecules and immunotherapies to reprogram immune signaling pathways in oncology and autoimmune diseases.

Company Info

Sector:Immuno-Oncology / Small Molecules

Headquarters:Atlanta, Georgia

Founded:2014

Website:www.georgiamune.com/

Clinical Development Pipeline

GIM-621

Target: First-in-class oral immune pathway reprogrammer

Solid Tumors

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Recent News

No recent news updates available for this company.

Leadership Team

Samir N. Khleif

Founder and Chief Executive Officer

Careers & Job Openings

No active job listings. Check back later.